ELIZABETH JEFFORDS: Open Payments
NPI 1891883005 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 52 payments from 16 companies in 2025. Trend: 2023 $1,132 · 2024 $1,165 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $132 |
| Corium, LLC | 7 | $116 |
| Supernus Pharmaceuticals, Inc. | 6 | $116 |
| Lundbeck LLC | 5 | $97 |
| Alkermes, Inc. | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| ABBVIE INC. | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
Products named: REXULTI, Azstarys, Qelbree, ARISTADA, TRINTELLIX, Jornay PM, CAPLYTA, VRAYLAR.
Industry payments across SC — which companies pay providers there.
